Comparison 6. Nevirapine twice daily versus efavirenz.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
1 Treatment failure on or before week 48	1	787	Risk Ratio (M‐H, Random, 95% CI)	1.16 [0.98, 1.37]
2 Undetectable plasma HIV RNA < 50 copies/ml at 48 weeks	1	787	Risk Ratio (M‐H, Random, 95% CI)	0.93 [0.85, 1.03]
3 Death	1	787	Risk Ratio (M‐H, Random, 95% CI)	1.33 [0.50, 3.53]